Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB1210

Introduced
4/19/23  

Caption

NBACC Authorization Act of 2023 National Biodefense Analysis and Countermeasures Center Authorization Act of 2023

Impact

If enacted, SB1210 would amend the Homeland Security Act of 2002 to formally recognize and empower the National Biodefense Analysis and Countermeasures Center as a crucial part of the federal biodefense infrastructure. This recognition entails not only providing authority to the Secretary of Homeland Security for its operation but also mandates continuous assessments of laboratory capabilities to ensure they accommodate future needs and evolving threats. These actions are intended to enhance the Nation's readiness and resilience against biological threats, thereby contributing to overall national security.

Summary

Senate Bill 1210, officially known as the 'National Biodefense Analysis and Countermeasures Center Authorization Act of 2023', aims to designate a specific laboratory as the lead federal facility dedicated to addressing biological threats. This measure emphasizes understanding the risks associated with biological events—whether intentional, accidental, or natural—and aims to bolster the federal government's abilities in investigating and responding to potential biocrimes and bioterrorism. The bill ensures comprehensive measures for biodefense, which may include conducting essential studies and forensic analyses in the event of biological attacks.

Contention

While SB1210 has garnered support from various quarters eager to improve the nation’s biodefense posture, concerns remain regarding funding allocations and the potential bureaucratic expansion associated with new federal laboratories. Critics may argue about the effectiveness and efficiency of state responses in biodefense, questioning whether such centralized efforts will lead to tangible improvements or merely add another layer of federal oversight without sufficient accountability. Ensuring that local and state agencies can effectively collaborate with the newly designated center will be a critical factor in the success of this initiative.

Companion Bills

US HB2791

Same As NBACC Authorization Act of 2023 National Biodefense Analysis and Countermeasures Center Authorization Act of 2023

Previously Filed As

US HB2791

NBACC Authorization Act of 2023 National Biodefense Analysis and Countermeasures Center Authorization Act of 2023

US SB2170

Depriving Enemy Nations of Integral Authorizations and Licenses Act of 2023 DENIAL Act of 2023

US HB1669

VET–TEC Authorization Act of 2023

US SB2226

National Defense Authorization Act for Fiscal Year 2024 Military Construction Authorization Act for Fiscal Year 2024 Securing Maritime Data from China Act of 2023 Military Service Promotion Act of 2023 Space Force Personnel Management Act Department of Defense Overdose Data Act of 2023

US SB199

Root and Stem Project Authorization Act of 2023

US SB1122

Prioritizing Medical Countermeasures for National Security Act of 2023

US SB2043

Department of State Authorization Act of 2023

US HB2741

Coast Guard Authorization Act of 2023

US HJR52

Authorization for Use of Military Force Resolution of 2023

US HB3932

Intelligence Authorization Act for Fiscal Year 2024

Similar Bills

US HB2791

NBACC Authorization Act of 2023 National Biodefense Analysis and Countermeasures Center Authorization Act of 2023

US SB501

Strategy for Public Health Preparedness and Response to Artificial Intelligence Threats

US SB2346

Strategy for Public Health Preparedness and Response to Artificial Intelligence Threats

US SB1798

Offices of Countering Weapons of Mass Destruction and Health Security Act of 2023

US SB4581

SUPER BUGS Act of 2024 Saving Us from Pandemic Era Resistance by Building a Unified Global Strategy Act of 2024

PA HB2368

In Commonwealth services, providing for emergency stockpiles and medical countermeasures.

NJ S3561

Permits procurement of medical countermeasures, products, and therapeutics.

NJ A4325

Permits procurement of medical countermeasures, products, and therapeutics.